Oncternal Therapeutics Stock Annual Yield
Oncternal Therapeutics fundamentals help investors to digest information that contributes to Oncternal Therapeutics' financial success or failures. It also enables traders to predict the movement of Oncternal Stock. The fundamental analysis module provides a way to measure Oncternal Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Oncternal Therapeutics stock.
Oncternal |
Oncternal Therapeutics Company Annual Yield Analysis
Oncternal Therapeutics' Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
CompetitionIn accordance with the recently published financial statements, Oncternal Therapeutics has an Annual Yield of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
All Next | Launch Module |
Oncternal Fundamentals
Return On Equity | -1.5 | ||||
Return On Asset | -0.76 | ||||
Operating Margin | (17.57) % | ||||
Current Valuation | (12.83 M) | ||||
Shares Outstanding | 2.96 M | ||||
Shares Owned By Insiders | 9.23 % | ||||
Shares Owned By Institutions | 12.07 % | ||||
Number Of Shares Shorted | 14.21 K | ||||
Price To Earning | (37.77) X | ||||
Price To Book | 0.17 X | ||||
Price To Sales | 0.72 X | ||||
Revenue | 785 K | ||||
Gross Profit | (31.49 M) | ||||
EBITDA | 2.23 M | ||||
Net Income | (39.48 M) | ||||
Cash And Equivalents | 78.9 M | ||||
Cash Per Share | 1.48 X | ||||
Total Debt | 318 K | ||||
Debt To Equity | 0 % | ||||
Current Ratio | 10.78 X | ||||
Book Value Per Share | 3.09 X | ||||
Cash Flow From Operations | (32.16 M) | ||||
Short Ratio | 0.09 X | ||||
Earnings Per Share | (11.69) X | ||||
Target Price | 2.0 | ||||
Number Of Employees | 27 | ||||
Beta | 1.33 | ||||
Market Capitalization | 1.56 M | ||||
Total Asset | 36.73 M | ||||
Retained Earnings | (197.78 M) | ||||
Working Capital | 30.86 M | ||||
Current Asset | 27.27 M | ||||
Current Liabilities | 6.3 M | ||||
Net Asset | 36.73 M |
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Oncternal Stock
If you are still planning to invest in Oncternal Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncternal Therapeutics' history and understand the potential risks before investing.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |